Cytotoxic Drugs Flashcards
(34 cards)
Anthracyclines and other cytotoxic antibiotics
- Doxorubicin
- Epirubicin
- Idarubicin
- Mitoxantrone
- Bleomycin
- Mitomycin
Vinca alkaloids
Vinblastine
Vincrisine
Vindesine
Vinorelbine
Antimetabolites
Azathioprine
Alkylating drugs
Cyclophosphamide Itosfamide
Mephalan
Lomustine
Camustine
Estramustine
Mitobronitol
Cytotoxic drugs
- have both anti cancer activity and potential to damage normal tissue
- given to prolong life, to cure or alleviate symptoms
- Cause side effects so need a balance between benefit and risk
- Side effects of cytotoxic drugs occur days or weeks after administration. Be aware of symptoms
- Most cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester
- exclude pregnancy before treatment
Neoadjuvant therapy
- chemotherapy and radio therapy OR chemotherapy and surgery OR chemotherapy and surgery and radiotherapy
- initial chemotherapy is aimed at shrinking the primary tumour, thereby rendering local therapy less destructive or more effective
Adjuvant therapy
Chemotherapy and Radiotherapy OR Chemotherapy and surgery OR chemotherapy and surgery and radiotherapy
- to prevent cancer after neoadjuvant treatment
Guidelines for handling cytotoxic drugs:
1) Trained personnel should reconstitute cytotoxics
2) Reconstitution should be carried out in designated pharmacy areas
3)Protective clothing(including gloves, gowns and mask) should be worn
4) the eyes should be protected and means of first aid specified
5) pregnant staff should avoid exposure to cytotoxic drugs(all females of child bearing age should be informed of reproductive hazards)
6) Use local procedures for dealing with spillages and safe disposal of waste material, including syringes,container and absorbent material
7) staff exposure to cytotoxic should be monitored
Safe systems for cytotoxic medicines
Safe systems -
- Cytotoxic drugs for the treatment of cancer should be given as part of a wider pathway of care coordinated by a multidisciplinary team
- Cytotoxic drugs should be prescribed, dispensed and administered only in the context of a written protocol or treatment plan
- injectable cytotoxic drugs should only be dispensed if they are prepared for administration
- oral cytotoxic medicines should only be dispensed with clear direction of use
Cytotoxic drugs important safety information
Risk of incorrect dosing of oral anti cancer medication:
- non specialist who prescribes or administers on-going oral cytotoxics should have access to written protocols and treatment plans including guidance on monitoring and treatment of toxicity
- staff dispensing oral cytotoxic meds should confirm that the prescribed dose is appropriate for the patient
- patients should have written information that includes details of the intended oral anti cancer regimens, the treatment plans, arrangements for monitoring taken from original protocol from the hospital
- Staff dispensing oral cytotoxic meds also have access to this information and to advice from an experienced cancer pharmacist in the initiating hospital
Extravasation of intravenous drugs
Severe local tissue necrosis if leakage into extravascular compartment occurs, reduce risk by using trained staff
Oral Musositis
Sore throat common chemotherapy complication - associated with flurouracil, anthacyclines and methotrexate - FLAME. Prevent with good oral hygiene ( rinse and brush frequently) and use saline,mouth wash. For flurouracil sucking on ice chips during short infusions may be useful
Tumour lysis
Rapid destruction of malignant cells. Pre existing hyperuricaemia,dehydration and renal impairment are predisposing factors.Features such as hyperkalaemia,hyperuricaemia,hypocalcaemia, hyperphosphataemia,renal damage and arrhythmias can follow
Hyperuricaemia
Present in leukaemia and high grade lymphoma can be worsened by chemotherapy associated with acute renal failure.Treat patients with allopurinol 24hrs before treating tumours. Other drugs can be given - febuxostat or rasburicase
Bone marrow suppression with cytotoxics
- all cytotoxics except vincristine and bleomycin cause bone marrow suppression
- check blood count before treatment
- treat any infection before starting cytotoxic drugs
- treat fever with antibiotics
- advise patient to see doctor promptly if having signs of infection
- blood transfusion for anaemia
Alopecia
Reversible hair loss is very common
Pregnancy and reproductive function
- most cytotoxics are teratogenic
- avoid especially in 1st trimester
- exclude pregnancy before treating with cytotoxic drugs
- provide contraceptive advice before chemo begins
Cytotoxic induced nausea and vomiting
- nausea and vomitting causes a lot of distress in patients receiving chemo. May lead to refusal of further treatment, Prophylaxis for nausea and vomiting is very important
- symptoms may be acute - so occurring 24hrs of treatment, delayed - first occurring more than 24hrs after treating or anticipatory - occurring prior to subsequent doses
- delayed and anticipatory symptoms are difficult to control than acute and require different management
Patients who are more susceptible to drug induced nausea and vomiting
- susceptibility varies between patients, following patients are more susceptible:
- women
- patients under 50
- anxious patients
- patients experiencing motion sickness
- with repeated exposure to cytotoxic drugs
Mildly Emetogenic
- Flurouracil
- Methotrexate
- Etoposide
- Vinca alkaloids
- Abdominal radiotherapy
Moderately emetogenic
Taxanes - doxitaxel and paclitaxel
Doxorubicin
Intermediate and low doses of cyclophsphamides
High doses of methotrexate, mitoxantrone
Highly emetogenic
Cisplatin
High doses of cyclophosphamide
Dacarbazine
Prevention of nausea and vomitting
- acute symptoms: patients at low risk of emesis (dexamethasone or lorazepam) patients at high risk (5 HT3 receptor antagonists) in combination with dexamethasone and aprepitant (neurokinin receptor antagonists)
- delayed symptom: moderately emetogenic chemotherapy, use dexamethasone +5HT3 antagonists. For highly emetogenic chemotherapy, use (dexamethasone+ aprepitant), metoclopramide and rolapitant also licenses
- anticipatory - lorazepam